Avior Wealth Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-141
Closed -$5.58K 2269
2024
Q4
$5.58K Buy
141
+95
+207% +$3.6K ﹤0.01% 1827
2024
Q3
$1.56K Buy
+46
New +$1.29K ﹤0.01% 2019
2024
Q2
Sell
-338
Closed -$7.49K 3681
2024
Q1
$7.49K Buy
+338
New +$8.25K ﹤0.01% 1959

Other funds holding VCYT

Avior Wealth Management's VCYT Position: Q1 2025 in Review

Avior Wealth Management sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 141 shares — an estimated $5.58K sold.

Avior Wealth Management first reported a position in VCYT in Q1 2024 and held it in 3 quarters. The position peaked at $7.49K in Q1 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Avior Wealth Management reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 141 Veracyte shares in Q1 2025, an estimated $5.58K.
  • Avior Wealth Management first reported a position in Veracyte in Q1 2024 and held it in 3 quarters.
  • Avior Wealth Management's Veracyte position peaked at $7.49K in Q1 2024.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.